Literature DB >> 7914474

Genetic toxicity and potential carcinogenicity of taxol.

H Tinwell1, J Ashby.   

Abstract

The activity of the antineoplastic agent taxol depends upon its ability to inhibit tubulin disassembly in dividing cells. We show here that taxol gives a strong positive response in the mouse bone marrow micronucleus assay. This is the first report of its genetic toxicity. The majority of antineoplastic agents are carcinogenic to humans, and the majority of human carcinogens are active in the mouse bone marrow micronucleus assay. The present data therefore indicate a carcinogenic potential of taxol for humans, which should be considered in the risk-benefit analysis of its increasing clinical use.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7914474     DOI: 10.1093/carcin/15.8.1499

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  7 in total

Review 1.  Chemoprotection of normal tissues by transfer of drug resistance genes.

Authors:  J A Rafferty; I Hickson; N Chinnasamy; L S Lashford; G P Margison; T M Dexter; L J Fairbairn
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

Review 2.  Integrating nanomedicine into clinical radiotherapy regimens.

Authors:  Allison N DuRoss; Megan J Neufeld; Shushan Rana; Charles R Thomas; Conroy Sun
Journal:  Adv Drug Deliv Rev       Date:  2019-07-04       Impact factor: 15.470

3.  Identification of 12Cysbeta on tubulin as the binding site of tubulyzine.

Authors:  Yeoun Jin Kim; Dan L Sackett; Matthieu Schapira; Daniel P Walsh; Jaeki Min; Lewis K Pannell; Young-Tae Chang
Journal:  Bioorg Med Chem       Date:  2005-11-02       Impact factor: 3.641

4.  Replication stress induces micronuclei comprising of aggregated DNA double-strand breaks.

Authors:  Bing Xu; Zhaoliang Sun; Zhaojian Liu; Haiyang Guo; Qiao Liu; Haiyan Jiang; Yongxin Zou; Yaoqin Gong; Jay A Tischfield; Changshun Shao
Journal:  PLoS One       Date:  2011-04-15       Impact factor: 3.240

Review 5.  Preclinical profile of cabazitaxel.

Authors:  Patricia Vrignaud; Dorothée Semiond; Veronique Benning; Eric Beys; Hervé Bouchard; Sunil Gupta
Journal:  Drug Des Devel Ther       Date:  2014-10-13       Impact factor: 4.162

6.  Paclitaxel resistance in untransformed human mammary epithelial cells is associated with an aneuploidy-prone phenotype.

Authors:  B P Bouchet; J Bertholon; N Falette; C Audoynaud; C Lamblot; A Puisieux; C M Galmarini
Journal:  Br J Cancer       Date:  2007-10-30       Impact factor: 7.640

7.  Transient impact of paclitaxel on mouse fertility and protective effect of gonadotropin‑releasing hormone agonist.

Authors:  Nieying Ma; Ge Chen; Jing Chen; Mengge Cui; Ye Yin; Qiuyue Liao; Minghui Tang; Xue Feng; Xi Li; Sijia Zhang; Ding Ma; Gang Chen; Kezhen Li; Jihui Ai
Journal:  Oncol Rep       Date:  2020-08-19       Impact factor: 3.906

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.